Table 1.
Author and Publication Year |
Setting (I)npatient (O)utpatient (P)opulation |
Study type |
Years | Early - onset SLE (n) |
Late - onset SLE (n) |
Late - onset Age Def. |
Newcastle Ottawa Score |
---|---|---|---|---|---|---|---|
Alonso 201219 | Spain; I | cohort | 1987–2006 | 91 | 59 | ≥50* | 6 |
Antolin 19958 | Spain; I | cohort | 1980–1992 | 134 | 29 | >50 | 7 |
Appenzeller 200820 | Brazil; I | c-c | 1974–2005 | 60 | 16 | ≥50* | 7 |
Boddaert 20041 | France; O | cohort | 1980–2000 | 114 | 47 | ≥50* | 6 |
Cartella 201321 | Italy; O | cohort | 1976–2008 | 495 | 40 | ≥50 | 6 |
Cervera 19939 | Europe; P | cohort | 1980–1990 | 910 | 90 | >50* | 6 |
Chen 200922 | Taiwan; I/O | cohort | 1998–2008 | 50 | 19 | ≥60* | 6 |
Cooper 200223 | USA; P | c-c | 1997–1999 | 195 | 61 | ≥50 | 6 |
Costallat 199413 | Brazil; O | cohort | 1973–1992 | 223 | 10 | ≥50* | 6 |
Dimant 19792 | USA: I/O | cohort | 1966–1976 | 218 | 16 | >50* | 6 |
Domenech 199210 | England; I/O | cohort | 1985–1991 | 232 | 15 | ≥50* | 6 |
Feng 201024 | China; I | cohort | unknown | 1550 | 131 | ≥50* | 5 |
Font 19913 | Spain; I/O | cohort | 1980–1988 | 210 | 40 | ≥50* | 6 |
Gomez 200625 | Spain; P | cohort | 1992-? | 259 | 91 | ≥50* | 6 |
Hashimoto 19874 | Japan; O | cohort | 1955–1985 | 501 | 21 | ≥50* | 6 |
Ho 199811 | China; O | cohort | 1971–1997 | 100 | 25 | >50* | 7 |
Jacobsen 199814 | Denmark; P | cohort | 1975–1995 | 354 | 103 | ≥50 | 6 |
Janwityanujit 199512 | Thailand; I | cohort | 1990–1992 | 308 | 27 | ≥50* | 7 |
Karoubi Nordon 20075 | France; O | c-c | 1995–2003 | 11 | 11 | ≥50 | 8 |
Lalani 201026 | Canada; P | cohort | 2005-? | 1367 | 161 | ≥50* | 6 |
Liu 198827 | Taiwan; I/O | cohort | 1977–1986 | 207 | 11 | ≥50* | 7 |
Maddison 198728 | England; O | cohort | unknown | 93 | 19 | >60* | 6 |
Mak 199829 | China; I | cohort | 1985–1995 | 89 | 13 | >50* | 6 |
Mok 200530 | China; I/O | cohort | 1991–2003 | 213 | 22 | >50* | 8 |
Pu 200031 | Taiwan; I | cohort | 1988–1998 | 152 | 42 | ≥50 | 6 |
Sayarlioglu 200432 | Turkey; O | cohort | 1978–2001 | 100 | 20 | ≥50* | 6 |
Shaikh 19956 | Malaysia; O | cohort | 1976–1992 | 52 | 17 | >50 | 6 |
Stefanidou 201333 | Greece; P | cohort | 1989–2007 | 430 | 121 | ≥50* | 6 |
Tang 201134 | China; O | cohort | 1986–2008 | 100 | 35 | ≥50 | 6 |
Tomic-Lucic 201335 | Serbia; O | c-c | unknown | 30 | 30 | ≥50 | 7 |
Voulgari 200236 | Greece; O | cohort | 1981–2000 | 398 | 90 | ≥55* | 7 |
Wang 20077 | China; I/O | cohort | 1999–2005 | 615 | 80 | ≥50* | 6 |
Webb 201137 | USA; P | cohort | unknown | 1038 | 168 | ≥50 | 5 |
Wilson 198138 | USA; O | cohort | 1970–1978 | 49 | 17 | ≥50* | 7 |
Xu 201139 | China; I | cohort | 2000–2008 | 241 | 30 | ≥50 | 6 |
TOTAL | 11189 | 1727 |
Abbreviations: c-c=case control;
indicates SLE patients < 18 years old included in analysis.